New Key Statistics Module, Z-Score and F-Score
OSTO:BIOVIT Key Ratios
| Market Cap kr M | 39.10 |
| Enterprise Value kr M | 37.64 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.19 |
| Price/Sales | 2.33 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 2.00 |
| EPS (TTM) kr | -0.16 |
| Beneish M-Score | -1.84 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 17.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.92 |
| EV-to-EBITDA | -11.82 |
| PEG | -- |
| Shares Outstanding M | 294.02 |
| Net Margin (%) | -492.58 |
| Operating Margin % | -495.10 |
| Pre-tax Margin (%) | -492.58 |
| Quick Ratio | 5.48 |
| Current Ratio | 6.91 |
| ROA % (ttm) | -44.39 |
| ROE % (ttm) | -52.74 |
| ROIC % (ttm) | -43.42 |
| Dividend Yield % | -- |
| Altman Z-Score | 45.04 |
OSTO:BIOVIT Number of Guru Trades
OSTO:BIOVIT Volume of Guru Trades
Gurus Latest Trades with OSTO:BIOVIT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OSTO:BIOVIT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers